Clinical Trials List
2013-09-01 - 2024-03-31
Phase III
Terminated11
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- SHUO-MENG WANG Division of Urology
- Yu-Chieh Tsai Division of Hematology & Oncology
- - - Division of Urology
- Chia-Chi Lin Division of Hematology & Oncology
- - - Division of Urology
- 戴槐青 Division of Urology
- CHUNG-HSIN CHEN Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Shian-Shiang Wang Division of Urology
- Chuan-Shu Chen Division of Urology
- Jian-Ri Li Division of Urology
- Cheng-Kuang Yang Division of Urology
- 熊小澐 Division of Radiology
- 歐宴泉 Division of Urology
- 林萬鈺 Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chi-Rei Yang Division of Urology
- Wen-Chi Chen Division of Urology
- Chi-Ping Huang Division of Urology
- Chao-Hsiang Chang Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Jian-Ri Li Division of Urology
- Shian-Shiang Wang Division of Urology
- 余家政 Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Yung-Chin Lee Division of Urology
- 黃俊農 Division of Urology
- Hung-Lung Ke Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 吳俊德 Division of Urology
- 范綱行 Division of Radiation Therapy
- 張英勛 Division of Hematology & Oncology
- 洪志宏 Division of Radiation Therapy
- Rita cheng Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 陳彥超 Division of Radiation Therapy
- 陳文祥 Division of Urology
- Pei-Hung Chang Division of Hematology & Oncology
- 林承家 Division of Urology
- 黃賢祥 Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Yi-Hsiu Huang Division of Urology
- Yen-Hwa Chang Division of Urology
- 沈書慧 Division of Urology
- 朱力行 Division of Urology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
132 participants
-
Global
1560 participants
